LEADER 02095nam  22005773u 450 
001 9910465459303321
005 20210108115716.0
010   $a1-78084-228-7
035   $a(CKB)2560000000152108
035   $a(EBL)1179640
035   $a(SSID)ssj0001599924
035   $a(PQKBManifestationID)16306517
035   $a(PQKBTitleCode)TC0001599924
035   $a(PQKBWorkID)14892692
035   $a(PQKB)10870922
035   $a(MiAaPQ)EBC1179640
035   $a(Au-PeEL)EBL1179640
035   $a(OCoLC)877767288
035   $a(EXLCZ)992560000000152108
100   $a20140421d2013||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aCurrent & Emerging Therapeutics for Multiple Myeloma$b[electronic resource]
205   $a1st ed.
210   $aLondon $cFuture Medicine Ltd$d2013
215   $a1 online resource (141 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-230-9 
327   $aTitle page; Copyright page; Contents; Foreword. Current and emerging therapeutics for multiple myeloma; 1. Current standard treatment of myeloma; 2. Stem cell transplantation; 3. New immune modulators; 4. Histone deacetylase inhibitors; 5. Targeted treatment of multiple myeloma: proteasome inhibitors; 6. AKT inhibitors in multiple myeloma; 7. Future directions; Index
330   $aCurrent & Emerging Therapeutics for Multiple Myeloma
606   $aMultiple myelom
606   $aMultiple myeloma -- Chemotherarpy
606   $aMultiple myeloma -- Treatment
608   $aElectronic books.
615  4$aMultiple myelom.
615  4$aMultiple myeloma -- Chemotherarpy.
615  4$aMultiple myeloma -- Treatment.
676   $a616.99/418
700   $aJagannath$b Sundar$01049727
702   $aRaje$b Noopur
702   $aJagannath$b Sundar
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910465459303321
996   $aCurrent & Emerging Therapeutics for Multiple Myeloma$92478982
997   $aUNINA